We are truly grateful for your efforts, support, and participation of the Annual Walk events and it will be amazing to walk, or stroll, with you on a path in a local park, or virtually on a path across the globe on September 25th from 9:00 a.m. – 12:00 p.m. EST
Walking, and Strolling, is a fun, and relaxing way to enjoy a change of scenery. Taking a stroll among the pleasant sights and sounds of nature, in-person or online, has the ability to renew the mind and body simultaneously. Walking with your family, and friends, for a cause is even better ~ as you join the manyC. diff. Awareness Walkers around the world sharing time to Raise C. diff. Awareness while spending time together to enjoy a way to add a little extra positive activity of the day.
All Registered Awareness Walkers will receive:
A C. diff. Awareness T-Shirt C. diff. Awareness Literature and Giveaways,
The opportunity to “Raise C. diff. Awareness” together worldwide!
* Children 10 years of age and under walk for free!
All items will be sent directly to all registered Awareness Walkers to the address provided in the registration.
To Register For This Global Event, Please Click On The Button Below:
We thank the Sponsors for their support of the global walks, and for joining us in “Raising C. diff. Awareness” across the globe.
Click on the graphics below to visit the Sponsor’s website and learn more about the organizations that are making a difference in the C. diff. community worldwide.
We are looking forward to seeing you in September!
Scientific Advisor Prof Dale Gerding to chair C. diff. Foundation
C. diff. Patient, Family, and Caregiver Symposium
July 16th – Live-Online beginning at 1:00 p.m. – 3:00 p.m. EDT
Brighton, United Kingdom – 02 July 2021 – Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines to prevent life-threatening infections, is pleased to announce that its Scientific Advisory Board member, Professor Dale Gerding, a world-leading expert in C. difficile infections (CDI) and the discoverer of NTCD-M3, will be chairing the “C. diff. Patient, Family, and Caregiver” Symposium, to be held virtually on 16 July 2021.
The Symposium, hosted by the C Diff Foundation, will be a gathering of healthcare professionals, practitioners, thought leaders, and C. diff. survivors focused on transforming the patient experience of people living with C. diff. infections worldwide.
Distinguished members and keynote speakers will provide insight on how to identify, evaluate, and prioritize innovations that can quickly touch the lives of patients battling C. diff. infections.
Destiny Pharma’s late-stage asset, NTCD-M3, is a novel microbiome therapeutic being developed to reduce the recurrence of C. diff. infections in the gut. CDI is the leading cause of hospital acquired infection in the US and current treatments lead to significant recurrence. In the US, there are approximately 500,000 cases of CDI each year; many of these initial cases then recur leading to 29,000 deaths per year.
NTCD-M3 has the potential to become the leading treatment for CDI, as it has shown to deliver clear advantages to both existing CDI treatment options and also to those currently in clinical development.
About Destiny Pharma plc Destiny Pharma is a UK based, clinical stage, innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections. Its pipeline has novel microbiome-based biotherapeutics and XF drug clinical assets including NTCD-M3, a Phase 3 ready treatment for the prevention of C. difficile infection (CDI) recurrence, which is the leading cause of hospital acquired infection in the US and also XF-73 nasal gel, which has recently completed a positive Phase 2b clinical trial targeting the prevention of post-surgical staphylococcal hospital infections including MRSA. It is also co-developing SPOR-COV, a novel, biotherapeutic product for the prevention of COVID-19 and other viral respiratory infections, and has earlier grant funded XF research projects.
A Bit of History……..
Thanksgiving Day, annual national holiday in the United States and Canada celebrating the harvest and other blessings of the past year. Americans generally believe that their Thanksgiving is modeled on a 1621 harvest feast shared by the English colonists (Pilgrims) of Plymouth and the Wampanoag people.
The Thanksgiving holiday holds special memories and meanings to everyone. This year the landscape of gatherings, and the social event has changed. We continue following guidelines to maintain our health, ward off acquiring the virus, keeping our children, families, and loved ones safe, as we continue maneuvering our way through these turbulent times caused by the Global COVID-19 virus pandemic.
On February 11, 2020, the World Health Organization announced an official name for the disease that is causing the 2019 novel coronavirus outbreak. The new name of this disease is coronavirus disease 2019, abbreviated as COVID-19. In COVID-19, ‘CO’ stands for ‘corona,’ ‘VI’ for ‘virus,’ and ‘D’ for disease. Formerly, this disease was referred to as “2019 novel coronavirus” or “2019-nCoV.” SARS-CoV-2 virus is a beta coronavirus, like MERS-CoV and SARS-CoV. Coronaviruses, named for the crown-like spikes on their surfaces, are a large family of viruses that are common in people and many different species of animals, including camels, cattle, cats, and bats. (1)
Our members reach out to you, your families, your friends, and associates with heart-felt greetings as we social-distance, visit through ZOOM, Facebook Messenger, and every app. available allowing us to virtually spend time with others. The way we connect for education, for business, for doctor visits, and in our families has changed. This Thanksgiving holiday gathering, along with special occasions earlier this year and the ones that are on the horizon, have a different landscape, a different feel to them, a different content. The one thing that has NOT changed? The love that we express through emails, through live online events, for the apps. we are utilizing to see others that mean so much to us. So today, let’s give thanks for the technology that has been created and that is available to us to connect virtually right now, while the scientists and medical science professionals continue working at developing a vaccine that will keep us safe, that will bring us all back together. It is what we do today that will make a significant difference tomorrow.
We share the gratitude for family members, for friends, and for the care teams, for the treatments and clinical trials available today to help resolve and prevent a C. diff. infection, recurrent C. diff. infections, along with the many wellness-draining diagnosis that our bodies endure at one time or another. Thank you, and a shout-out to the Infection Preventionists across the globe joining us during the annual campaign, “November is Raising C. diff. Awareness Month.” Thank you to the many State Governors proclaiming November Is Raising Clostridioides difficile Awareness Month. We are profoundly grateful!
Every day the gratitude pours out to the healthcare professionals devoting their lives to medical science, the research and development teams, the individuals and colleagues who give it their all in order to turn the infections around to improve our health safely, and effectively with products being developed. Through clinical trials, and the organizations enrolling individuals today, C. diff. infection studies for initial infections, recurrent C. diff. infections, and for the prevention of a C. diff. infection — you help them – to help you – to help others. You are NOT out of options!
As the Thanksgiving holiday arrives this year we send our best wishes, with an abundance of gratitude, to you, your family, friends, and to the health care professionals visiting the website, participating in the online events this year, for joining us at the 8th Annual International C. diff. Virtual Conference and Health EXPO, and for reaching out to us by telephone, emails, and for being part of the C Diff Foundation programs worldwide. We are here to help you through this infection, to continue recovering from this infection, to help others learn more about C. diff. infection prevention, treatments, clinical trials, diagnostics, environmental safety, and support around the globe. “Thank You.”
“None of us can do this alone ~ all of us can do this together.”
Microbiota Restoration in Recurrent C. difficile (C. diff. ) and COVID-19
This activity is intended for gastroenterologists, infectious disease specialists, and other clinicians who care for patients at risk of serious infection.
Activity Purpose: While the incidence of multiply recurrent C. difficile continues to rise, FMT has emerged as a means to break the cycle. Amid the current COVID-19 pandemic, clinicians should be aware of the additional safety concerns that have arisen. Expert faculty will discuss approaches to FMT including sourcing and screening of donor stool, which requires heightened safety measures during the COVID-19 pandemic. This activity is the first in a series of two educational activities that address the latest data on treating patients who experience rCDI.
Please click on the following link to be redirected to the activity